Avalo Therapeutics (NASDAQ:AVTX – Get Free Report) had its price objective dropped by HC Wainwright from $35.00 to $30.00 in a report released on Friday,Benzinga reports. According to data from MarketBeat, Avalo Therapeutics has an average rating of “Moderate Buy” and a consensus price target of $45.30. Get Avalo Therapeutics alerts:View Our Latest Analysis on Avalo TherapeuticsAvalo Therapeutics Trading Down 0.7%AVTX opened at $18.70 on Friday. The firm has a 50-day moving average price of $17.22 and a two-hundred day moving average price of $16.27. Featured ArticlesReceive News & Ratings for Avalo Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avalo Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.